Prohibition Partners will soon be launching the 10th addition of their industry leading European Cannabis Report, marking the milestone with a ground-up overhaul of its tried and trusted format.
In April 2025, Prohibition Partners will launch a new digital knowledge hub, offering readers the same in-depth and up-to-date analysis they’ve come to expect from the company, in an easy-to-navigate, consistently updated, interactive format.
The choice to transition away from a traditional point-in-time publishing schedule comes at a critical time for the industry, which has undergone transformational changes in the last 12 months.
In order to keep pace with the rapidly evolving regulatory landscape in real time, this new digital hub will act as a one-stop-shop for businesses, patients and stakeholders alike to gain valuable insight and analysis into 31 of the world’s most critical cannabis markets.
Its new always-on dynamic digital platform will feature interactive maps, real-time data visualisations, and continuously updated insights covering everything from regulations and pricing to domestic production, imports, and exports.
These insights will be built from the industry’s most in-depth datasets which have been a mainstay of Prohibition Partners reporting since 2017.
“Since 2017, we’ve been charting the evolution of cannabis markets across Europe, we knew it was time for something new that matched the pace, scale, and complexity of what’s happening on the ground,” Prohibition Partners CEO, Stephen Murphy, explained.
“This isn’t just a new edition of our report—it’s a complete reimagining of how we deliver insights and data. The digital knowledge hub gives businesses, policymakers, and patients real-time access to the data and analysis they need to navigate an industry that is no longer changing year by year, but week by week.”
Alongside these new, easily digestible resources painting a clear picture of the international cannabis framework across Europe, the site will also delve deep into individual markets pushing the boundaries of cannabis reform.
In Germany, landmark cannabis legislation enacted in April 2024 triggered a rapid restructuring of the medical market, while also giving rise to cultivation associations for adult-use cannabis across several federal states. However, political uncertainty now surrounds the country’s second-phase adult-use pilot programs, following a change in government led by the conservative CDU/CSU party.
Meanwhile, the Netherlands is preparing to roll out Europe’s largest-ever adult-use cannabis trial on April 7th, 2025. Ten municipalities, representing a population of over 1.6 million, will see coffee shops selling cannabis exclusively sourced from licensed and regulated supply chains—marking a historic shift in the country’s drug policy.
In Switzerland, seven adult-use cannabis trials are already underway. While full results have yet to be released, early indicators are promising. The Swiss National Council has formally adopted a proposal to draft legislation for the full legalisation of adult-use cannabis, with early drafts expected in the coming months.
On the medical front, the UK continues its steady climb, with a doubling of cannabis import volumes year-on-year, and the first UK-cultivated medical products now entering the market. Patient interest and clinical adoption are both growing as awareness expands. At the same time, Germany and the UK are positioning themselves as key European manufacturing hubs for medical cannabis extracts.
With a growing patchwork of regulations, production models, and patient access schemes across Europe, Prohibition Partners’ new digital format promises to be a vital tool for investors, policymakers, operators, and advocates. The hub is expected to be a cornerstone resource for those navigating the complexity of Europe’s fragmented but fast-expanding cannabis ecosystem.
